Stefan Schreiber
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (13)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Host-microbiota metabolic interactions critically regulate nicotinamide adenine dinucleotide (NAD+) homeostasis, and their disruption is increasingly linked to chronic diseases including inflammatory bowel disease (IBD). However, it remains unclear whether NAD+ dysregulation in IBD arises from impaired production, enhanced consumption, or both. Using multi-omics approaches and stable isotope-labeled NAD+ precursors administered via intravenous infusion in a murine model of dextran sulfate sodium (DSS)-induced colitis, we mapped tissue- and lumen-specific NAD+ metabolism under inflammatory stress. Our results reveal tissue-specific rewiring of NAD+ metabolism, with increased flux through the salvage pathway compensating for reduced de novo NAD+ synthesis from tryptophan. In parallel, microbial de novo NAD+ production was elevated, highlighting a cooperative host–microbiota response to inflammatory stress. These findings demonstrate differential regulation of NAD+ biosynthesis during acute colitis and underscore the dynamic interplay between host and microbial metabolism in maintaining NAD+ homeostasis under inflammatory conditions.
Year:
2025
Colorectal cancer, a leading cause of death in the Western world, is increasingly affecting younger populations. The Warburg effect, characterized by enhanced lactate production, is a hallmark of this cancer type. While 18 F-FDG PET-CT is commonly used for diagnosis, magnetic resonance imaging (MRI) offers higher spatial and chemical resolution without the drawbacks of radiation. However, MRI's low sensitivity has been a barrier to real-time metabolic imaging, hence implementation into clinical practice. Hyperpolarization has significantly boosted NMR sensitivity, enabling detailed metabolic studies in vivo. This study utilizes hyperpolarized [1- 13 C]pyruvate with dissolution dynamic nuclear polarization (dDNP) to non-invasively monitor metabolic changes in intestinal organoids from a genetically defined mouse model of spontaneous carcinogenesis ( Rnaseh2b/Xbp1 ΔIEC ) with a previously established targeted therapeutic intervention (mTOR inhibition by rapamycin). Hyperpolarized NMR revealed a significant reduction in lactate production in rapamycin-treated organoids, indicating suppressed metabolic activity. This method also detected alanine and bicarbonate metabolism, highlighting its sensitivity. Unlike traditional methods that destroy cellular integrity, hyperpolarization enables repetitive, non-invasive metabolic assessments, bridging the gap between preclinical and clinical applications and affirming the method's potential for targeted metabolic imaging as a novel diagnostic and treatment control approach in cancer medicine.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (15)
Edward Loftus
Professor of Medicine
Mayo Clinic Rochester
Melanie McReynolds
Pennsylvania State University
Mamoru Watanabe
Project Professor
Juntendo University
Sofia K. Forslund
Professor
Charité - Universitätsmedizin Berlin
Philip Rosenstiel
Kiel University
Jean Fred Colombel
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Konrad Aden
Proferssor of Gastroenterology and Metabolomics
Kiel University
Dong-Hyeon Kim
Prof. Dr.
Konkuk University
Remo Panaccione
Director, Inflammatory Bowel disease Unit, Professor of Medicine
University of Calgary
Stephen Hanauer
Professor of Medicine
Northwestern University
Edouard Louis
University of Liege
Jan‐Bernd Hövener
Kiel University
Marc Ferrante
-
Andrey N. Pravdivtsev
-
Stefan Rose-John
Professor and Head
Kiel University
Make your next move.
Prepare your application
Review drafts before you send them.